Nov 30 (Reuters) – Most patients who previously were not
helped by repeated treatments for multiple myeloma showed strong
benefits from a new type of therapy in a small study, and with
no worrisome…
The post Bluebird, Celgene myeloma treatment impresses in tiny study appeared first on NASDAQ.